Spots Global Cancer Trial Database for immtac
Every month we try and update this database with for immtac cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma | NCT02535078 | Malignant Melan... | Tebentafusp (IM... durvalumab tremelimumab | 18 Years - | Immunocore Ltd | |
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma | NCT03070392 | Uveal Melanoma | IMCgp100 Dacarbazine Ipilimumab Pembrolizumab | 18 Years - 99 Years | Immunocore Ltd | |
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma | NCT03070392 | Uveal Melanoma | IMCgp100 Dacarbazine Ipilimumab Pembrolizumab | 18 Years - 99 Years | Immunocore Ltd | |
A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp | NCT04960891 | Uveal Melanoma | Tebentafusp | 18 Years - | Immunocore Ltd |